Computational design and experimental confirmation of a disulfide-stapled YAP helix
TEA Domain Transcription Factors
Transcription Factors
/ chemistry
Humans
DNA-Binding Proteins
/ chemistry
Antineoplastic Agents
/ pharmacology
Molecular Dynamics Simulation
YAP-Signaling Proteins
Muscle Proteins
/ chemistry
Adaptor Proteins, Signal Transducing
/ chemistry
Disulfides
/ chemistry
Protein Binding
Binding Sites
Cell Line, Tumor
Computer-Aided Design
Drug Design
Disulfide stapling
Hippo signaling pathway
Rational molecular design
Transcriptional enhanced associate domain-4
YAP helixα1-trap
Yes-associated protein
Journal
Journal of computer-aided molecular design
ISSN: 1573-4951
Titre abrégé: J Comput Aided Mol Des
Pays: Netherlands
ID NLM: 8710425
Informations de publication
Date de publication:
23 Aug 2024
23 Aug 2024
Historique:
received:
07
04
2024
accepted:
14
08
2024
medline:
23
8
2024
pubmed:
23
8
2024
entrez:
23
8
2024
Statut:
epublish
Résumé
Human Hippo signaling pathway is an evolutionarily conserved regulator network that controls organ development and has been implicated in various cancers. Transcriptional enhanced associate domain-4 (TEAD4) is the final nuclear effector of Hippo pathway, which is activated by Yes-associated protein (YAP) through binding to two separated YAP regions of α1-helix and Ω-loop. Previous efforts have all been addressed on deriving peptide inhibitors from the YAP to target TEAD4. Instead, we herein attempted to rationally design a so-called 'YAP helix
Identifiants
pubmed: 39177727
doi: 10.1007/s10822-024-00572-2
pii: 10.1007/s10822-024-00572-2
doi:
Substances chimiques
TEA Domain Transcription Factors
0
Transcription Factors
0
TEAD4 protein, human
0
DNA-Binding Proteins
0
Antineoplastic Agents
0
YAP1 protein, human
0
YAP-Signaling Proteins
0
Muscle Proteins
0
Adaptor Proteins, Signal Transducing
0
Disulfides
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
31Subventions
Organisme : Jinggangshan University Startup Fund for Doctor Research
ID : JZB11035
Organisme : Jiangxi Provincial Natural Science Foundation
ID : 20202BABL206111
Organisme : Natural Science Foundation of Jiangxi Province
ID : 20202BABL206111
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Références
Harvey KF, Zhang X, Thomas DM (2013) The Hippo pathway and human cancer. Nat Rev Cancer 13:246–257
pubmed: 23467301
doi: 10.1038/nrc3458
Cunningham R, Hansen CG (2022) The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer. Clin Sci 136:197–222
doi: 10.1042/CS20201474
Zhou Y, Huang T, Cheng AS, Yu J, Kang W, To KF (2016) The TEAD family and its oncogenic role in promoting tumorigenesis. Int J Mol Sci 17:138
pubmed: 26805820
pmcid: 4730377
doi: 10.3390/ijms17010138
Hong W, Guan KL (2012) The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway. Semin Cell Dev Biol 23:785–793
pubmed: 22659496
pmcid: 3459069
doi: 10.1016/j.semcdb.2012.05.004
Santucci M, Vignudelli T, Ferrari S, Mor M, Scalvini L, Bolognesi ML, Uliassi E, Costi MP (2015) The Hippo pathway and YAP/TAZ-TEAD protein–protein interaction as targets for regenerative medicine and cancer treatment. J Med Chem 58:4857–4873
pubmed: 25719868
doi: 10.1021/jm501615v
Luo M, Xu Y, Chen H, Wu Y, Pang A, Hu J, Dong X, Che J, Yang H (2022) Advances of targeting the YAP/TAZ-TEAD complex in the hippo pathway for the treatment of cancers. Eur J Med Chem 244:114847
pubmed: 36265280
doi: 10.1016/j.ejmech.2022.114847
Wang S, Ye H, Shang S, Li Z, Peng Y, Zhou P (2024) A structure-based data set of protein-peptide affinities and its nonredundant benchmark: potential applications in computational peptidology. Curr Med Chem 26:1–10
Mesrouze Y, Bokhovchuk F, Meyerhofer M, Fontana P, Zimmermann C, Martin T, Delaunay C, Erdmann D, Schmelzle T, Chène P (2017) Dissection of the interaction between the intrinsically disordered YAP protein and the transcription factor TEAD. Elife 6:e25068
pubmed: 28430104
pmcid: 5400505
doi: 10.7554/eLife.25068
Furet P, Salem B, Mesrouze Y, Schmelzle T, Lewis I, Kallen J, Chène P (2019) Structure-based design of potent linear peptide inhibitors of the YAP–TEAD protein–protein interaction derived from the YAP Ω-loop sequence. Bioorg Med Chem Lett 29:2316–2319
pubmed: 31235263
doi: 10.1016/j.bmcl.2019.06.022
He B, Wu T, He P, Lv F, Liu H (2021) Structure-based derivation and optimization of YAP-like coactivator-derived peptides to selectively target TEAD family transcription factors by hydrocarbon stapling and cyclization. Chem Biol Drug Des 97:1129–1136
pubmed: 33283479
doi: 10.1111/cbdd.13813
Mesrouze Y, Gubler H, Villard F, Boesch R, Ottl J, Kallen J, Reid PC, Scheufler C, Marzinzik AL, Chène P (2023) Biochemical and structural characterization of a peptidic inhibitor of the YAP:TEAD interaction that binds to the α-helix pocket on TEAD. ACS Chem Biol 18:643–651
pubmed: 36825662
doi: 10.1021/acschembio.2c00936
Pobbati AV, Rubin BP (2020) Protein–protein interaction disruptors of the YAP/TAZ–TEAD transcriptional complex. Molecules 25:6001
pubmed: 33352993
pmcid: 7766469
doi: 10.3390/molecules25246001
Bai Z, Hou S, Zhang S, Li Z, Zhou P (2017) Targeting self-binding peptides as a novel strategy to regulate protein activity and function: a case study on the proto-oncogene tyrosine protein kinase c-Src. J Chem Inf Model 57:835–845
pubmed: 28345935
doi: 10.1021/acs.jcim.6b00673
Zhou P, Hou S, Bai Z, Li Z, Wang H, Chen Z, Meng Y (2018) Disrupting the intramolecular interaction between proto-oncogene c-Src SH3 domain and its self-binding peptide PPII with rationally designed peptide ligands. Artif Cells Nanomed Biotechnol 46:1122–1131
pubmed: 28754059
doi: 10.1080/21691401.2017.1360327
Zhang D, He D, Pan X, Liu L (2020) Rational design and intramolecular cyclization of hotspot peptide segments at YAP–TEAD4 complex interface. Protein Pept Lett 27:999–1006
pubmed: 32286937
doi: 10.2174/0929866527666200414160723
Zhang D, Wu H, Zhao J (2021) Computational design and experimental substantiation of conformationally constrained peptides from the complex interfaces of transcriptional enhanced associate domains with their cofactors in gastric cancer. Comput Biol Chem 94:107569
pubmed: 34500324
doi: 10.1016/j.compbiolchem.2021.107569
Gu H, Liu L (2021) Molecular modeling and rational design of noncovalent halogen∙∙∙oxygen∙∙∙hydrogen motif at the complex interface of EGFR kinase domain with RALT peptide. Chem Phys 550:111309
doi: 10.1016/j.chemphys.2021.111309
Zhang D, He D, Pan X, Xu Y, Liu L (2019) Structural analysis and rational design of orthogonal stacking system in an E. coli DegP PDZ1–peptide complex. Chem Pap 73:2469–2476
doi: 10.1007/s11696-019-00797-8
Mesrouze Y, Bokhovchuk F, Izaac A, Meyerhofer M, Zimmermann C, Fontana P, Schmelzle T, Erdmann D, Furet P, Kallen J, Chène P (2018) Adaptation of the bound intrinsically disordered protein YAP to mutations at the YAP:TEAD interface. Protein Sci 27:1810–1820
pubmed: 30058229
pmcid: 6199158
doi: 10.1002/pro.3493
Krivov GG, Shapovalov MV, Dunbrack RL (2009) Improved prediction of protein side-chain conformations with SCWRL4. Proteins 77:778–795
pubmed: 19603484
pmcid: 2885146
doi: 10.1002/prot.22488
Duan Y, Wu C, Chowdhury S, Lee MC, Xiong G, Zhang W, Yang R, Cieplak P, Luo R, Lee T, Caldwell J, Wang J, Kollman P (2003) A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J Comput Chem 24:1999–2012
pubmed: 14531054
doi: 10.1002/jcc.10349
Hess B, Kutzner C, van der Spoel D, Lindahl E (2008) GROMACS4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput 4:435–447
pubmed: 26620784
doi: 10.1021/ct700301q
Zhou P, Yan F, Miao Q, Chen Z, Wang H (2021) Why the first self-binding peptide of human c-Src kinase does not contain class II motif but can bind to its cognate Src homology 3 domain in class II mode? J Biomol Struct Dyn 39:310–318
pubmed: 31872783
doi: 10.1080/07391102.2019.1709547
Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79:926–935
doi: 10.1063/1.445869
Ni J, Zhong Z, Lu W, Li S, Shao X, Hang L (2024) Systematic profiling of mitogen-inducible gene 6 and its derived peptides binding to receptor tyrosine kinases in bone cancers at molecular and cellular levels. Int J Pept Res Ther 30:8
doi: 10.1007/s10989-023-10585-4
Yang C, Zhang S, He P, Wang C, Huang J, Zhou P (2015) Self-binding peptides: folding or binding? J Chem Inf Model 55:329–342
pubmed: 25643174
doi: 10.1021/ci500522v
Yang C, Zhang S, Bai Z, Hou S, Wu D, Huang J, Zhou P (2016) A two-step binding mechanism for the self-binding peptide recognition of target domains. Mol Biosyst 12:1201–1213
pubmed: 26854254
doi: 10.1039/C5MB00800J
Darden T, York D, Pedersen L (1993) Particle Mesh Ewald: an N∙Log(N) method for Ewald sums in large systems. J Chem Phys 98:10089–10092
doi: 10.1063/1.464397
Hess B, Bekker H, Berendsen HJC, Fraaije JGEM (1997) LINCS: a linear constraint solver for molecular simulations. J Comput Chem 18:1463–1472
doi: 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
Genheden S, Ryde U (2015) The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 10:449–461
pubmed: 25835573
pmcid: 4487606
doi: 10.1517/17460441.2015.1032936
Chang CE, Chen W, Gilson MK (2005) Evaluating the accuracy of the Quasiharmonic approximation. J Chem Theory Comput 1:1017–1028
pubmed: 26641917
doi: 10.1021/ct0500904
Zhou P, Wen L, Lin J, Mei L, Liu Q, Shang S, Li J, Shu J (2022) Integrated unsupervised-supervised modeling and prediction of protein-peptide affinities at structural level. Brief Bioinform 23:bbac097
pubmed: 35352094
doi: 10.1093/bib/bbac097
Li Z, Miao Q, Yan F, Meng Y, Zhou P (2019) Machine learning in quantitative protein-peptide affinity prediction: implications for therapeutic peptide design. Curr Drug Metab 20:170–176
pubmed: 30317994
doi: 10.2174/1389200219666181012151944
Lin J, Wen L, Zhou Y, Wang S, Ye H, Su J, Li J, Shu J, Huang J, Zhou P (2023) PepQSAR: a comprehensive data source and information platform for peptide quantitative structure-activity relationships. Amino Acids 55:235–242
pubmed: 36474016
doi: 10.1007/s00726-022-03219-4
Zhou P, Liu Q, Wu T, Miao Q, Shang S, Wang H, Chen Z, Wang S, Wang H (2021) Systematic comparison and comprehensive evaluation of 80 amino acid descriptors in peptide QSAR modeling. J Chem Inf Model 61:1718–1731
pubmed: 33710894
doi: 10.1021/acs.jcim.0c01370
Zhu H, Xu S, Wu J, Hu J, Mao X (2022) Molecular design and rational optimization of synergistic effect between the two wings of a roughly orthogonal cation-π-π stacking system at nasopharyngeal carcinoma YAP1–TEAD4 parallel Helix-Helix interaction interface. J Mol Recognit 35:e2986
pubmed: 36326001
doi: 10.1002/jmr.2986
Greenfield NJ (2006) Using circular dichroism spectra to estimate protein secondary structure. Nat Protoc 1:2876–2890
pubmed: 17406547
pmcid: 2728378
doi: 10.1038/nprot.2006.202
Yan T, Zhang Y, Liu L, Shi Z, Sun T, Yang J, Xue L, Shi X, Sha N (2023) Targeting peptide-mediated interaction between the N-protein and P-protein of human pediatric respiratory syncytial virus by molecular design of chemically stapled helical peptides. J Chin Chem Soc 70:1835–1846
doi: 10.1002/jccs.202300123
Chen YH, Yang JT, Chau KH (1974) Determination of the helix and beta form of proteins in aqueous solution by circular dichroism. Biochemistry 13:3350–3359
pubmed: 4366945
doi: 10.1021/bi00713a027
Brooks H, Lebleu B, Vivès E (2005) Tat peptide-mediated cellular delivery: back to basics. Adv Drug Deliv Rev 57:559–577
pubmed: 15722164
doi: 10.1016/j.addr.2004.12.001
Zhao L, Huang Q, Tian S, Ge J, Zhu H, Dong Q (2019) Integrative identification of unexpected kinase-inhibitor interactions in the MAPK-mediated proliferation and differentiation of Mc3T3-E1 osteoblasts. Gen Physiol Biophys 38:1–13
pubmed: 30657460
doi: 10.4149/gpb_2018030
Zhou P, Tian F, Shang Z (2009) 2D depiction of nonbonding interactions for protein complexes. J Comput Chem 30:940–951
pubmed: 18942722
doi: 10.1002/jcc.21109
UniProt C (2023) UniProt: the universal protein knowledgebase in 2023. Nucleic Acids Res 51:D523–D531
doi: 10.1093/nar/gkac1052
Wang J, Zhang J, Sun X, Liu C, Li X, Chen L (2019) Molecular design of sequence-minimized, structure-optimized, and hydrocarbon-stapled helix-helix interactions in the trimer-of-hairpins motif of pediatric pneumonia RSV-F protein. Chem Biol Drug Des 94:1292–1299
pubmed: 30776182
doi: 10.1111/cbdd.13501
Lin J, Wang S, Wen L, Ye H, Shang S, Li J, Shu J, Zhou P (2023) Targeting peptide-mediated interactions in omics. Proteomics 23:e2200175
pubmed: 36461811
doi: 10.1002/pmic.202200175
Shu J, Li J, Wang S, Lin J, Wen L, Ye H, Zhou P (2023) Systematic analysis and comparison of peptide specificity and selectivity between their cognate receptors and noncognate decoys. J Mol Recognit 36:e3006
pubmed: 36579779
doi: 10.1002/jmr.3006
Mei L, Shang S, Wang S, Ye H, Zhou P (2023) Machine annealing-guided navigation of antihypertensive food peptide selectivity between human ACE N- and C-domains in structurally interacting diversity space. J Mol Recognit 36:e3014
pubmed: 37014036
doi: 10.1002/jmr.3014
Yin F, Dong J, Kang LI, Liu X (2021) Hippo-YAP signaling in digestive system tumors. Am J Cancer Res 11:2495–2507
pubmed: 34249412
pmcid: 8263672
Wu D, Luo L, Yang Z, Chen Y, Quan Y, Min Z (2021) Targeting human hippo TEAD binding interface with YAP/TAZ-derived, flexibility-reduced peptides in gastric cancer. Int J Pept Res Ther 27:119–128
doi: 10.1007/s10989-020-10069-9
Chen F, Wang Q, Mu Y, Sun S, Yuan X, Shang P, Ji B (2022) Systematic profiling and identification of the peptide-mediated interactions between human Yes-associated protein and its partners in esophageal cancer. J Mol Recognit 35:e2947
pubmed: 34964176
doi: 10.1002/jmr.2947